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Abstract
Both the upper (endocervix and uterus) and lower (ectocervix and vagina) female genital tract mucosa are considered to be
target sites for sexual transmission of HIV. There are a few reports on the T cell and antigen-presenting cell distribution in
human endometrial tissue however, there is little known about the expression of the HIV co-receptor CCR5 and HIV-binding
C-type lectin receptors on endometrial cell subsets. We therefore assessed endometrial tissue sections from HIV
seronegative women undergoing hysterectomy of a benign and non-inflammatory cause for phenotypic characterization of
potential HIV target cells and receptors by immunohistochemistry. Langerin was expressed on intraepithelial CD1a+CD4+
and CD11c+CD4+ Langerhans cells. Furthermore, CCR5+CD4+CD3+ T cells, DC-SIGN+MR+CD11c+ myeloid dendritic cells
and MR+CD68+ macrophages were found within or adjacent to the epithelium of the uterine lumen. In addition, occasional
CD123+ BDCA-2+ plasmacytoid dendritic cells were detected deep in the endometrial stroma. Both T cells and several
antigen-presenting cells were detected in lymphoid aggregate formations in close proximity to the epithelial lining. The
finding of intraepithelial and stromal Langerin+ cells as well as CCR5+ CD4+ T cells is novel for human endometrium.
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Introduction
The female genital tract is responsible for two complex tasks;
creating an environment for fertilization and protection against
potential pathogens. As all other mucosal sites the female genital
tract is exposed to a wide range of pathogens, not the least sexually
transmitted infections such as the human immunodeficiency virus
type 1 (HIV). The uterus and the endocervix are protected by the
cervical mucus, which contains numerous antiviral innate immune
molecules as well as constitutes a physical barrier. Despite this,
sperm and radioactive microspheres enter the uterus within
minutes after placement in the vagina [1,2]. Semen from an HIV
positive individual contains free virions and infected leucocytes. In
addition, spermatozoa can capture HIV and transmit the virus to
dendritic cells (DCs) [3]. Thus, the DC population may together
with other target cells contribute to initial HIV transmission events
in the endometrium and therefore needs further characterization.
Even when intact, the single layer columnar epithelium lining
the endocervix and uterus is a less robust barrier to pathogens as
compared to the multilayered squamous epithelium lining the
ectocervix and vagina. Thus, invading pathogens may more easily
access potential mucosal HIV target cells such as CD4+ T cells,
DCs and macrophages. In addition to CD4+ T cells, which have
previously been identified in human endometrial tissue [4,5,6],
Langerhans cells (LCs), interstitial DCs and macrophages are all
target cells for HIV. These cells can bind the virus through
conventional binding to CD4 and the main co-receptor CCR5 as
well as other receptor pathways including C-type lectin receptors
(CLRs) [7]. Little is known about the presence of CLRs such as the
mannose receptor (MR) [8,9], the DC-specific intercellular
adhesion molecule-grabbing intergrin (DC-SIGN) [10] and
Langerin [11] in the human endometrium. The relative
importance of primary HIV entry and infection through the
different pathways is affected by the location, timing and
concentration of the inoculum and host factors. For example,
under non-inflammatory conditions immature LCs may form a
barrier against HIV infection by efficiently capturing and
degrading the virus through Langerin, rather than binding HIV
and subsequently transferring the infectious virus particles to other
target cells [12].
In this report we characterize potential HIV target cells and
cellular receptors in the human endometrium, which constitutes
an accessible site to incoming pathogens upon sexual intercourse
[13].
Material and Methods
Study population and sample collection
Endometrial tissue sections from the uterine corpus were
obtained from eight women undergoing hysterectomy for non-
malignant and non-inflammatory indications (leiomyomata and
adenomyosis); mean age was 48 years (range 39–52 years). The
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symptoms of sexually transmitted infections during the prior three
months and no use of hormonal therapy. The hysterectomy
samples were immediately transported on ice to the pathology
department where a pathologist specializing in gynecological
specimens collected endometrial tissue sections. A blinded
pathologist determined all samples for menstrual cycle stage by
endometrial dating. Two study subjects were in the proliferative
phase, three were in the secretory phase and three had an inactive
endometrium. Written informed consent was obtained from all
study subjects and ethical approval was obtained from the
Regional Ethical Review Board in Stockholm.
In situ detection of cellular markers by immunostaining
and confocal microscopy
The endometrial tissue sections were processed and snap frozen
in liquid nitrogen within 30 minutes of surgical removal. Following
previous protocols [14,15] the cryopreserved tissue samples were
sectioned to 8 mm and fixed in 2% formaldehyde. Selected anti-
human monoclonal and polyclonal antibodies were used to detect
the immune markers of interest: Langerin (clone: AF2088), DC-
SIGN (clone: 120507) DLEC (BDCA-2 clone: AF1376) (R&D
systems, Minneapolis, MN) MR (clone: 19.2) CD11c (clone: B-ly6)
CD123 (clone: 9F5), CD123 (clone: 7G3), HLA-DR (clone: L243),
CD4 (clone: SK3), CD8 (clone: SK1), CD3 (clone: SK7) (Becton
Dickinson, Franklin Lakes, NJ) CD1a (clone: NA/1/34-HLK)
(Serotec, Du ¨sseldorf, Germany), CD68 (clone: EBM11) (DAKO,
Stockholm, Sweden) and CCR5 (clone: MC-5) (kindly provided by
Professor M. Mack from the University Clinic of Regensburg,
Germany). The staining reactions were developed brown by using
diaminobenzidine tetrahydrochloride (DAB; Vector Laboratories,
Burlingame, CA) and nuclear counterstaining was performed with
hematoxylin. Digital images were transferred from a DMR-X
microscope (Leica, Wetzlar, Germany) into a computerized image
analysis system, Quantimet, Q 550 IW (Leica Imaging Systems,
Cambridge, UK). For 1 and 2-color fluorescent staining,
combinations of relevant antibodies were used followed by the
appropriate Alexa Fluor–conjugated secondary antibody. Fluor-
escently labeled cells were evaluated using the Qwin 550 software
and a filter-free spectral confocal microscope (Leica TCS SP2
AOBS). Negative control staining consisted of irrelevant mouse,
rat or goat IgG (Dako).
Quantitative analysis
Expression of the markers of interest was analyzed in a median
of 1.9610
7 mm
2 endometrial tissue section per individual (range
1.3–2.4610
7 mm
2), including the: luminal epithelium; lamina
superficialis; lamina basalis and the glandular epithelium
(Figure 1). The myometrium was excluded from all analysis. All
calculations were performed manually in Adobe Photoshop CS3
(Adobe Systems Incorporated, San Jose, CA) and all tissue sections
were scanned and assessed in duplicates with result variations less
than 10%.
Results
CD4 is considered to be the main receptor for HIV and is
commonly expressed on T-cells (here defined as CD3+) but also on
antigen-presenting cells. In this study, scattered CD4+ cells were
detected throughout the endometrial epithelium and stroma of all
study subjects (n=8) (median: 0.005 positive cells/100 mm
2 tissue
[range: 0.003–0.009 positive cells/100 mm
2 tissue]) and 3–22% of
these cells were either detected within or adjacent (#50 mm) to the
luminal epithelium (Figure 2). Also, clusters of CD4+ cells were
detected in lymphoid aggregate formations adjacent to the luminal
and glandular epithelium of all study subjects (median size of
aggregate: 1.7610
4 mm
2 [range: 0.2–4.9610
4 mm
2]). Approxi-
mately 30–50% of the scattered CD4+ cells were CD3+ T cells,
whereas 100% of the CD4+ cells in lymphoid aggregate
formations were CD3+ T cells (Figure 2). CCR5, the main co-
receptor for HIV, was expressed on scattered CD4+ cells, CD4+
cells in lymphoid aggregates (Figure 2) and on CD3+ cells (data
not shown).
Antigen-presenting cells can express HIV-binding CLRs that
may facilitate viral transmission across mucosal surfaces. The
presence of such cells was thus characterized in the endometrial
tissue samples. LCs, macrophages, myeloid DCs (mDCs), and
plasmacytoid DCs (pDCs) were here defined as CD1a+; CD68+;
CD11c+ and CD123+BDCA-2+ cells, respectively. CD1a+ cells
were rare (median: 0.0003 positive cells/100 mm
2 tissue [range:
0.0001–0.001 positive cells/100 mm
2 tissue]) and mainly detected
within the luminal (40–60%) or glandular (45–60%) epithelium
(Figure 3). The CD1a+ cells co-expressed CD11c and CD4
(Figure 3) and were occasionally detected within stromal
CD4+CD3+ lymphoid aggregates (Figure 2). CD68+ and
CD11c+ cells were more abundant (median: 0.009 and 0.008
positive cells/100 mm
2 tissue, respectively [range: 0.006–0.01 and
0.007–0.01 positive cells/100 mm
2 tissue, respectively]). Both
CD68+ and CD11c+ cells were detected within the luminal
epithelium (11–18% and 18–35%, respectively) and in stromal
lymphoid aggregate formations (Figure 3). A subset of CD11c+
cells co-expressed CD4+ (data not shown). CD123+ cells were
solely present in the stroma, both as individual scattered cells and
organized in streak formations. CD123 is expressed by pDCs but
may also be expressed by additional cell types, thus a
Figure 1. Schematic picture of the uterus. Schematic picture
showing the myometrium and the different components of the human
endometrium: I: luminal epithelium; II: lamina superficialis; III: lamina
basalis; IV: myometrium and V: glandular epithelium. Quantitative
assessment of endometrial tissue samples was performed in all sections
but the myometrium.
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was a vast difference in the number of CD123+ and BDCA-2+
cells (median: 0.006 and 0.0002 positive cells/100 mm
2 tissue,
respectively [range: 0.002–0.008 and 0.0001–0.0004 positive
cells/100 mm
2 tissue, respectively]), however, all BDCA-2+ cells
were CD123+ (Figure 3). BDCA-2+ cells were distinctly diverse
from all other investigated cell populations, although they were
occasionally detected in close proximity to each other.
Although HIV efficiently binds to CD4 and CCR5, the virus
can also bind to CLRs including Langerin, DC-SIGN and MR.
Langerin+ cells were distributed throughout the endometrial
tissues of all study subjects (median: 0.003 positive cells/
100 mm
2 tissue [range: 0.002–0.009 positive cells/100 mm
2
tissue]) and 11–39% of these cells were either detected within
or adjacent (#50 mm) to the luminal epithelium (Figure 4). The
Langerin+ c e l l se x p r e s s e dC D 1 a ,C D 1 1 c ,a n dC D 4 ,b u tn o t
CD68 and were detected within stromal lymphoid aggregates
(Figure 4). Neither DC-SIGN nor MR were detected within the
luminal epithelium, although both CLRs were detected in close
proximity (minimum distance to lumen: 49 mma n d4 0 mm,
respectively). Both DC-SIGN and MR were expressed on
CD68+ and CD11c+ cells but not on CD1a+ cells (Figure 4).
The CD123+BDCA-2+ cells did not express any of the
investigated CLRs (data not shown).
Discussion
In this report we have demonstrated the presence of
intraepithelial Langerin, CCR5 and CD4 expressing cells in
human endometrium. These molecules are known HIV
receptors and could thus serve as potential HIV-binding
targets. Furthermore, the presence of stromal lymphoid
aggregates, containing cells expressing Langerin, CCR5,
CD4, CD11c and CD68 could hypothetically constitute a site
for HIV replication as well as a functional site for local immune
responses. Although such aggregates have previously been
described in endometrial [4,16,17,18,19] and ectocervical
tissue [20], but not in other parts of the human female genital
tract under non-inflammatory conditions, the presence of
potential HIV receptors such as Langerin have not. Previous
findings of CCR5 expression in human endometrium [21] and
uterine epithelial cells [22] have now been extended with
phenotypic characterization in both the intraepithelial and
stromal compartment.
The CD1a+CD4+CD11c+CD68- LC phenotype has been
found at other mucosal sites [23] whereas single layer columnar
epithelium has been proposed to lack Langerin+ LCs [24]. Yet,
occasional CD1a+ cells have been detected in human first
trimester deciduas [25] and non-pregnant endometrium [4,26].
Figure 2. Endometrial CD4+cells express CCR5. (a) Scattered CD4+ cells were detected in the luminal and glandular epithelium as well as both
stromal locations (lamina superficialis and lamina basalis). (b) Clusters of CD4+ cells were also detected just beneath the luminal epithelium and (c)
adjacent to glandular epithelium. (d) A majority of the scattered CD4+ cells (red) co-expressed (yellow) CD3+ (green). (e) The lymphoid aggregate
formations contained vast numbers of CD3+ cells (red) and occasional CD1a+ cells (green). (f) A positive co-localization (yellow) of CCR5+ cells (red)
and CD4+ cells (green) was frequently observed both in the luminal epithelium and underlying stroma and (g) in the lymphoid aggregate formations.
Arrowheads indicate example of double-positive staining; arrows indicate single-positive staining. Scale bars: a: 500 mm; b, c: 100 mm; d–f: 25 mm.
doi:10.1371/journal.pone.0021344.g002
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pregnant women with non-inflammatory underlying conditions,
we suggest that LCs can be constitutively expressed in the
endometrial columnar epithelium, however their role in HIV
transmission events at this site remain to be established. The
conflicting results regarding the presence of rare CD1a+ LCs may
be due to different staining techniques, amount of tissue
investigated and type of study subjects. In addition to
CCR5+CD4+CD3+ T-cells and Langerin+CD1a+CD11c+ LCs,
additional HIV target cells including DC-SIGN+MR+CD11c+
mDCs, and MR+CD68+ macrophages were also widely distrib-
uted in the superficial layer of the endometrial stroma and may
thus theoretically be accessible for HIV-infection following sexual
intercourse.
Figure 3. Distribution of antigen-presenting cell subsets in human endometrium. (a) CD1a+ cells were rare and mainly found within the
luminal or glandular epithelium. (b) CD1a+ cells (green) co-expressed (yellow) CD11c+ (red), although not all CD11c+ cells expressed CD1a. (c) The
CD1a+ cells (green) also expressed CD4 (red). (d) CD11c+ and (e) CD68+ cells were present in much higher frequencies in both the epithelium and
stroma and clusters of both (f) CD11c+ and (g) CD68+ cells were present in the lamina basalis adjacent to glandular epithelium (marked area:
7.1610
4 mm
2 and 8.1610
4 mm
2, respectively). (h) CD123+ cells were solely present in the stroma as scattered cells and in streak formations. (i) Some
but not all CD123+ (red) cells co-localized (yellow) with BDCA-2 (green). BDCA-2+ (green) neither co-localized with (j) CD11c+ (red) nor (k) CD68+ (red)
cells, although they were occasionally detected in close proximity to each other. Arrowheads indicate example of positive staining. Scale bars: a:
500 mm; b, c, j, k: 25 mm; d–i: 100 mm.
doi:10.1371/journal.pone.0021344.g003
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in the stroma and a small subgroup of the scattered cells co-
expressed BDCA-2, a phenotype specific for pDCs. These cells did
not express any of the investigated CLRs. To our knowledge this is
the first time CD123+BDCA-2+ pDCs have been shown in
human non-inflamed endometrial tissue although the number of
cells was very low. By using immunohistochemistry we could
determine the exact localization of these double-stained cells,
specifically in relation to the endometrial lumen and thereby
extend previous studies that used flow cytometry on tissue extracts
from human deciduas [27]. As blood-derived pDCs down-regulate
their BDCA-2 expression upon in vitro maturation [28], the
detected CD123+ BDCA-2- cells may constitute mature pDCs or
basophils [29]. pDCs have been implicated as important mediators
of immune activity in response to virus exposure in the endocervix
[30], a mechanism that would be interesting to explore also in the
uterus.
It must be remembered that the type and number of immune
related cells changes throughout the menstrual cycle and with
underlying medication, hormonal contraceptive use, disease or
pregnancy [5,6,26,31,32]. Furthermore, the regional variations in
histology and the size of the uterus complicate adequate
assessment of cell populations. The study individuals in this report
represented three different stages of the menstrual cycle. A similar
distribution of all investigated cell populations and receptors were
observed within their respective endometrium, however due to the
small size of the study groups no inter or intra-group statistical
analysis was performed. Future studies need to expand each study
group to statistically verify variations in immune cell populations.
Nevertheless, the present demonstrations of Langerin+ LCs,
CCR5+ T cells and CD123+BDCA-2+ pDCs were novel
observations at this anatomical site. The quantitative assessment
showed a generally low number of the investigated cellular
markers in the endometrial stroma. This was especially true for the
BDCA2+CD123+ cells and the LC associated marker CD1a. In
comparison with the immune cell numbers in the squamous
cervicovaginal epithelium [31] the endometrial stroma exhibits a
relative paucity of immune cells. However, this discrepancy must
be considered with the regional differences in histology and
function in mind.
The major site of HIV penetration into the female genital tract
mucosa following vaginal intercourse is not clear. As single layer
epithelium may be more easily traversed by HIV compared to
multilayer epithelium [33], and since semen can reach the uterus
following sexual intercourse, the endometrium might serve as
target for HIV. Indeed, HIV has been shown to infect cells and
tissues from the uterus representing all stages of the menstrual
cycle as well as postmenopausal women in ex vivo models [34].
Figure 4. CLR expression on various DC subsets present in the endometrium. (a) Langerin positive cells were mainly detected within the
luminal and glandular epithelium. Positive co-localization (yellow) was detected with Langerin+ cells (green) and (b) CD1a (red) and (c) CD11c (red).
(d) Double-positive cells (yellow) expressing Langerin+ (green) and CD4+ (red) cells were also detected within CD4+ lymphoid aggregates. (e) DC-
SIGN and (f) MR were detected in the lamina superficialis, just beneath the luminal epithelium (I: minimum distance of cell body to endometrial
lumen: 49 mm and 40 mm, respectively). Both (g) DC-SIGN (green) and (h) MR(green) were co-expressed (yellow) on CD68+ cells (red) as well as (i and
j, respectively) CD11c+ cells (red). Neither (k) DC-SIGN (red) nor (l) MR (red) were expressed on CD1a+ (green) cells. Scale bars: a: 500 mm; b–d: 25 mm;
e–l: 100 mm.
doi:10.1371/journal.pone.0021344.g004
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expressing HIV-binding receptors adds to earlier reports on the
distribution of HIV target cells in human endometrium [22],
ectocervical tissue [14,32,35] and vagina [31,36,37].
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